What are the criteria for diagnosing diabetic ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Diabetic Ketoacidosis (DKA)

DKA is diagnosed when blood glucose is >250 mg/dL (or prior diabetes history), venous pH <7.3, serum bicarbonate <15 mEq/L, and moderate ketonuria or ketonemia are all present together. 1

Core Diagnostic Triad

The American Diabetes Association defines DKA by three simultaneous criteria 1:

  • Hyperglycemia: Blood glucose >250 mg/dL 1
  • Metabolic acidosis: Venous pH <7.3 AND serum bicarbonate <15 mEq/L 1
  • Ketosis: Moderate ketonuria or ketonemia (preferably measured as β-hydroxybutyrate in blood) 1

Important caveat: Approximately 10% of DKA cases present as euglycemic DKA with glucose <200 mg/dL, particularly in patients on SGLT2 inhibitors, pregnant patients, those with reduced food intake, or chronic alcohol use. 2 In these cases, the diagnosis still requires pH <7.3, bicarbonate <15 mEq/L, and elevated ketones despite "normal" glucose. 2

Severity Classification

DKA severity is stratified based on pH and bicarbonate levels 1:

  • Mild DKA: Venous pH 7.25-7.30, bicarbonate 15-18 mEq/L, alert mental status 1
  • Moderate DKA: Venous pH 7.00-7.24, bicarbonate 10-15 mEq/L, drowsy mental status 1
  • Severe DKA: Venous pH <7.00, bicarbonate <10 mEq/L, associated with higher morbidity and mortality requiring intensive monitoring 1

Essential Laboratory Workup

Upon presentation with suspected DKA, immediately obtain 1:

  • Complete metabolic panel (electrolytes, BUN, creatinine)
  • Venous blood gas (arterial not necessary for initial diagnosis)
  • Complete blood count
  • Urinalysis
  • Serum β-hydroxybutyrate (preferred over urine ketones)
  • Calculate anion gap: [Na⁺] - ([Cl⁻] + [HCO₃⁻]), which should be >10-12 mEq/L 1
  • Correct sodium for hyperglycemia: [measured Na] + [(glucose - 100)/100] × 1.6 1

If infection is suspected, obtain bacterial cultures of urine, blood, and throat. 1

Critical Pitfall: Ketone Measurement

Never rely on urine ketones or nitroprusside-based tests for diagnosis or monitoring. 1 These methods only detect acetoacetate and acetone, completely missing β-hydroxybutyrate—the predominant ketoacid in DKA. 1 During treatment, β-hydroxybutyrate converts to acetoacetate, paradoxically making nitroprusside tests appear worse even as the patient improves. 1 Direct blood β-hydroxybutyrate measurement is the gold standard. 1

Resolution Criteria

DKA is considered resolved when all of the following are met 3:

  • Glucose <200 mg/dL 3
  • Serum bicarbonate ≥18 mEq/L 3
  • Venous pH >7.3 3
  • Anion gap ≤12 mEq/L 3

Do not stop insulin therapy based on glucose normalization alone—ketoacidosis typically takes longer to clear than hyperglycemia. 2 Continue insulin infusion until all resolution criteria are met, adding dextrose to IV fluids when glucose falls below 250 mg/dL to prevent hypoglycemia while clearing ketones. 1

Special Populations at Risk

Risk factors for euglycemic DKA include 2:

  • SGLT2 inhibitor use (0.6-4.9 events per 1,000 patient-years) 2
  • Pregnancy (up to 2% of pregestational diabetes pregnancies) 2
  • Reduced food intake/starvation 2
  • Chronic alcohol use 2
  • Chronic liver disease 2

Patients with type 1 diabetes, younger age, prior DKA history, high A1C, very-low-carbohydrate diets, prolonged fasting, or missed insulin doses are at highest risk. 2

References

Guideline

Diagnostic Criteria and Management of Diabetic Ketoacidosis (DKA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diabetic Ketoacidosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Resolving Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.